Project Number GC-2013542 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2018 View Full Project Details for Resilience Biomarker NPTX2 and AD Progression Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers a. CSF Biomarkers Researcher and Organization Principal Investigator Worley, Paul Principal Investigator First Name Paul Principal Investigator Last Name Worley Awardee Organization Johns Hopkins School of Medicine Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement Neuroimaging and CSF Biomarker Development RFP FY Overall Cost $160,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
